Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02732821 · ClinicalTrials.gov registry record
G-POEM for Treatment of Refractory Gastroparesis
A clinical trial of Diabetic Gastroparesis and Idiopathic Gastroparesis, sponsored by Johns Hopkins University.
- Completed
- Registry status
- 80
- Enrollment target
- 1
- Study location
NCT02732821 is a study of Diabetic Gastroparesis and Idiopathic Gastroparesis that has completed, run by Johns Hopkins University. The registered enrollment target is 80 participants, below the 150-participant average among 7 other Diabetic Gastroparesis trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02732821, a study of Diabetic Gastroparesis and Idiopathic Gastroparesis, has completed, sponsored by Johns Hopkins University.
- COMPLETED
- Registry status
- 80 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is performed to assess the efficacy and outcomes of Gastric Per Oral Endoscopic Myotomy "G-POEM" in patients presenting with gastroparesis.
Conditions Studied
Interventions
- PROCEDURE Gastric Per Oral Endoscopic Myotomy
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2015-05 |
| Est. Completion | 2020-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02732821
The ClinicalTrials.gov registry entry for NCT02732821 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 150-participant average among 7 other Diabetic Gastroparesis trials with a reported enrollment target (47% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Diabetic Gastroparesis appearing as the primary indexed condition, and to 1 intervention - of which Gastric Per Oral Endoscopic Myotomy is the first listed.
NCT02732821 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT02732821 about?
NCT02732821 is a clinical study titled "G-POEM for Treatment of Refractory Gastroparesis". This study is performed to assess the efficacy and outcomes of Gastric Per Oral Endoscopic Myotomy "G-POEM" in patients presenting with gastroparesis.
What is the current status of trial NCT02732821?
This trial is currently completed. The enrollment target is 80 participants. The study started on 2015-05. Estimated completion is 2020-04.
What conditions does trial NCT02732821 study?
This clinical trial studies the following conditions: Diabetic Gastroparesis, Idiopathic Gastroparesis, Gastroparesis Postoperative.
What interventions are being tested in trial NCT02732821?
The interventions under investigation include: Gastric Per Oral Endoscopic Myotomy (PROCEDURE).
Who is sponsoring clinical trial NCT02732821?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02732821 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Gastroparesis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Pyloric Sphincter Abnormalities in Patients With Gastroparesis Symptoms
RECRUITING
-
Thoracic Neuromodulation for Diabetic Gastroparesis
RECRUITING · Phase 1
-
A Study to Evaluate the Safety and Efficacy of NG101 in Adult Participants With Symptomatic Diabetic or Idiopathic Gastroparesis
COMPLETED · Phase 2
-
A Study to Evaluate the Efficacy and Safety of TAK-906 in Adult Participants With Symptomatic Idiopathic or Diabetic Gastroparesis
COMPLETED · Phase 2
-
Biomagnetic Characterization of Gastric Dysrhythmias III
COMPLETED · Early Phase 1
-
A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adults With Diabetic Gastroparesis
COMPLETED · Phase 2
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.